Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Moodys
AstraZeneca
Baxter
Dow

Last Updated: August 14, 2022

Details for New Drug Application (NDA): 020118


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 020118 describes SUPRANE, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three suppliers. Additional details are available on the SUPRANE profile page.

The generic ingredient in SUPRANE is desflurane. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.
Summary for 020118
Tradename:SUPRANE
Applicant:Baxter Hlthcare
Ingredient:desflurane
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020118
Physiological EffectGeneral Anesthesia
Suppliers and Packaging for NDA: 020118
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUPRANE desflurane LIQUID;INHALATION 020118 NDA Henry Schein, Inc. 0404-9961 0404-9961-25 1 BOTTLE in 1 BAG (0404-9961-25) > 240 mL in 1 BOTTLE
SUPRANE desflurane LIQUID;INHALATION 020118 NDA Baxter Healthcare Corporation 10019-641 10019-641-24 6 BOTTLE, GLASS in 1 CARTON (10019-641-24) > 240 mL in 1 BOTTLE, GLASS (10019-641-60)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LIQUID;INHALATIONStrength100%
Approval Date:Sep 18, 1992TE:ANRLD:Yes

Expired US Patents for NDA 020118

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 See Plans and Pricing See Plans and Pricing
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Johnson and Johnson
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.